Temozolomide as salvage treatment in primary brain lymphomas

Methotrexate (MTX)-based chemotherapy extends survival in patients with primary brain lymphomas, but it is not clear whether multiagent chemotherapy is superior to MTX alone. Treatment options for patients with recurrent primary brain lymphoma are limited; there is no standard second-line chemothera...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Reni, M, Zaja, F, Mason, W, Perry, J, Mazza, E, Spina, M, Bordonaro, R, Ilariucci, F, Faedi, M, Corazzelli, G, Manno, P, Franceschi, E, Pace, A, Candela, M, Abbadessa, A, Stelitano, C, Latte, G, Ferreri, A J M
Format: Artigo
Idioma:Inglês
Publicat: Nature Publishing Group 2007
Matèries:
Clinical Study
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC2360092/
https://ncbi.nlm.nih.gov/pubmed/17325700
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/sj.bjc.6603660
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars